Steven J. Burakoff
Director/Board Member at The Damon Runyon Cancer Research Foundation
Profile
Steven J.
Burakoff is currently the Director at The Damon Runyon Cancer Research Foundation and a Professor of Medicine, Hematology & Medical Oncology at Icahn School of Medicine at Mount Sinai.
He previously held positions as Director & Chairman-Pediatric Oncology at Dana-Farber Cancer Institute, Director at Ligand Pharmaceuticals, Genzyme Corp., and Pharmacopeia LLC, and Director at The Mount Sinai Hospital.
He was also a Professor and Director-Skirball Biomolecular Medicine Institute at New York University.
Burakoff received his graduate degree from Queens College, undergraduate degree from Lehigh University, and doctorate from Albany Medical College.
Steven J. Burakoff active positions
| Companies | Position | Start |
|---|---|---|
The Damon Runyon Cancer Research Foundation
 The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services The Damon Runyon Cancer Research Foundation supports cancer research through grants to scientists in fields including cellular biology, genetics, immunology, and virology. It was founded in 1946 and is headquartered in New York City, NY. | Director/Board Member | - |
| Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | 2011-03-03 |
Former positions of Steven J. Burakoff
| Companies | Position | End |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Director/Board Member | 2009-12-31 |
Pharmacopeia LLC
 Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Director/Board Member | 2008-12-22 |
| New York University | Corporate Officer/Principal | 2006-12-31 |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Director/Board Member | 1999-12-31 |
| New York University | Corporate Officer/Principal | - |
Training of Steven J. Burakoff
| Lehigh University | Undergraduate Degree |
| Queens College | Graduate Degree |
| Albany Medical College | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| Private companies | 5 |
|---|---|
Pharmacopeia LLC
Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Health Technology |
The Damon Runyon Cancer Research Foundation
The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services The Damon Runyon Cancer Research Foundation supports cancer research through grants to scientists in fields including cellular biology, genetics, immunology, and virology. It was founded in 1946 and is headquartered in New York City, NY. | Commercial Services |
The Mount Sinai Hospital
 The Mount Sinai Hospital Hospital/Nursing ManagementHealth Services The Mount Sinai Hospital provides medical and healthcare services. The company was founded in 1952 and is headquartered in New York, NY. | Health Services |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
- Stock Market
- Insiders
- Steven J. Burakoff
